PROVIDER PROFILE · NPI 1225230154

Shen-Han LinD.O.

PRACTICESHEN-HAN LIN MEDICAL PCSee all providers at this practice →

Family PracticeFlushing, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

404

Unique beneficiaries

—

Total services

1,117

Distinct HCPCS

Medicare payment

$68K

Peer benchmark

Total Medicare services vs. 3,705 Family Practice providers in NY — top quintile (cohort median 473).

PRESCRIBING · PART D · 2024

Total Rx claims

14,447

Beneficiaries

—

Total drug cost

$2.6M

Distinct drugs

168

Brand share

30.7%

Top prescribed drugs

Icosapent Ethyl830 claims

Atorvastatin Calcium770 claims

Diclofenac Epolamine628 claims

Amlodipine Besylate533 claims

Losartan Potassium477 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Food and Beverage$2K

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 330106

Hospital

REFERRAL NETWORK

Where Shen-Han Lin's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	23	42
BETH ISRAEL MEDICAL CENTER	19	46

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
AHRC HEALTH CARE INC	56	124
BETH ISRAEL MEDICAL CENTER	17	33
Sunrise Medical Laboratories, Inc. Clinical Laboratory · Hicksville, NY	14	16

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history